Device/Diagnostics Quarterly Deal Statistics, Q3 2013

A look at financing, M&A, and alliance activity, July–September 2013

11 Dec 2013

Device and diagnostics companies both suffered declines in fundraising compared with previous quarters. The biggest medtech acquisition was Stryker’s $1.4 billion buyout of MAKO, while in diagnostics BioMeriux’s $450 million purchase of BioFire topped the list.

Medical device developers closed the third quarter of 2013 with $644 million in financing, a big decline compared with the previous two quarters, which each tallied both tallied over $1 billion in funding.

Early-stage venture investing saw the sharpest drop vs. Q2, decreasing 37% from $179 million to $113 million. Still there was...